Altria Group stock gets higher outlook after resilient Q3

Altria Group Inc. reported resilient third-quarter results on October 29, 2026, and raised its full-year adjusted earnings outlook. In the company's investor release, management said adjusted diluted earnings per share grew 4.8% from the year-earlier quarter to 1.52 US dollars.

Altria Group stock traded at 70.48 euros on Lang & Schwarz at 13:09 CET on Friday, November 13, 2026.

Higher outlook follows resilient quarter

Net revenue rose 1.0% to 6.132 billion US dollars in the third quarter, while revenue net of excise taxes increased 3.6% to 5.441 billion US dollars. Reported diluted earnings per share advanced 7.1% to 1.51 US dollars. The adjusted figures exclude special items, so the adjusted earnings measure is not a GAAP result.

Altria now expects full-year 2026 adjusted diluted earnings per share of 5.66 to 5.74 US dollars, compared with a 2025 adjusted base of 5.42 US dollars. The company said the range implies growth of 4.5% to 6.0% and reflects performance through the first nine months as well as confidence in its full-year plan.

The board also authorized a 1 billion US dollar expansion of the existing share repurchase program. The authorization now runs through December 31, 2027. Altria repurchased 5.9 million shares for 400 million US dollars during the quarter and 11.2 million shares for 735 million US dollars in the first nine months.

Pricing supports core tobacco business

Smokeable products remained the main earnings engine. Segment revenue increased 0.8%, while revenue net of excise taxes rose 3.7%. Adjusted operating companies income gained 3.9% to 3.072 billion US dollars, and the adjusted margin edged up to 64.5%. Higher pricing and refunds of taxes and duties supported profitability, but promotional investment, lower shipment volume and an unfavorable volume mix weighed on performance.

Domestic cigarette shipment volume fell 2.9% in the quarter, while Marlboro shipment volume declined 6.4%. Discount cigarette volume increased 40.5%, indicating that consumer income pressure continues to influence product mix. The figures show how pricing can protect earnings even as underlying cigarette demand contracts.

Smoke-free progress remains uneven

The oral tobacco segment highlights the execution risk behind Altria's longer-term transition. Quarterly net revenue slipped 0.1%, adjusted operating companies income fell 3.7%, and adjusted margin declined to 66.4%. Total oral tobacco shipment volume decreased 4.3%, although on! volume increased 13.3% and the company continued expanding its on! PLUS nicotine pouch range.

For investors, the higher earnings outlook and larger buyback improve the near-term shareholder-return profile. The counterpoint is that the core business still depends on pricing and cash generation while cigarette volumes decline, and the smoke-free portfolio has not yet delivered consistent segment growth.

The broader US equity market is tracked through the S&P 500.

More news and analyses on Altria Group stock.